HALOZYME THERAPEUTICS INC (HALO) Institutional Ownership Changes & 13F Activity

HALOZYME THERAPEUTICS INC (HALO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Hancock Classic Value, Torray Fund, Sequoia Financial Advisors, and First Eagle U.S. Value.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2019Renaissance Technologies LLCBuy760,0001,218,600$21,606
Q4 2019Torray FundBuy5,47951,832$919
Q4 2019First Eagle U.S. ValueSell-1,0001,636,475$29,015
Q3 2019First Eagle U.S. ValueSell-490,8001,637,475$25,397
Q3 2019Torray FundBuy11046,353$719
Q2 2019Renaissance Technologies LLCSell-290,800458,600$7,879
Q2 2019Torray FundSell-5,58446,243$794
Q1 2019Renaissance Technologies LLCBuy444,800749,400$12,065
Q1 2019First Eagle U.S. ValueSell-2,5002,128,275$34,265
Q4 2018Renaissance Technologies LLCSell-286,000304,600$4,456
Q4 2018Miller Value PartnersSell-150,00020,000$293
Q4 2018First Eagle U.S. ValueSell-42,3142,130,775$31,173
Q4 2018Torray FundBuy7,95151,827$758
Q3 2018Renaissance Technologies LLCSell-302,800590,600$10,731
Q3 2018First Eagle U.S. ValueBuy48,5262,173,089$39,485
Q3 2018Torray FundBuy6,32443,876$797
Q2 2018First Eagle U.S. ValueSell-880,1902,124,563$35,841
Q2 2018Torray FundSell-1,48837,552$634
Q1 2018First Eagle U.S. ValueSell-1,526,3283,004,753$58,863
Q1 2018Renaissance Technologies LLCBuy156,800893,400$17,502
Q1 2018Torray FundBuy45239,040$765
Q4 2017First Eagle U.S. ValueSell-1,913,9004,531,081$91,800
Q4 2017Renaissance Technologies LLCBuy721,900736,600$14,924
Q4 2017Torray FundBuy8,64338,588$782
Q3 2017First Eagle U.S. ValueSell-949,3346,444,981$111,949
Q3 2017Miller Value PartnersSell-779,800170,000$2,953
Q3 2017Torray FundBuy25829,945$520
Q2 2017Miller Value PartnersBuy949,800949,800$12,176
Q2 2017Torray FundSell-1,09929,687$381
Q1 2017First Eagle U.S. ValueSell-293,2007,394,315$95,830

Frequently asked questions about HALO activity

  • Which institutional owners are buying HALO?

    Institutional owners buying HALO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in HALO activity?

    "Buy" means an investor increased their reported position in HALO compared to the prior reporting period. This reflects growing exposure to HALOZYME THERAPEUTICS INC (HALO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in HALO increasing?

    Institutional interest in HALO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related HALO Institutional Insights